The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Pharmacology and Management of the Vitamin K Antagonists
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_9 · Cited by 3,476
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., & Deykin, D. (2001) · Chest · doi:10.1378/chest.119.1_suppl.8s · Cited by 1,804
Self-citationComparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Kasner, S. E., Benesch, C. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043033 · Cited by 1,744
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Self-citationThe management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
Rieder, M. J., Reiner, A. P., Gage, B. F., Nickerson, D. A., Eby, C. S., McLeod, H. L., Blough, D. K., Thummel, K. E., Veenstra, D. L., & Rettie, A. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044503 · Cited by 1,399
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Self-citationEffect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Self-citationOsteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone
Hauschka, P. V., Lian, J. B., Cole, D. E., & Gundberg, C. M. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.990 · Cited by 1,272
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Mayer, S. A., Brun, N. C., Begtrup, K., Broderick, J., Davis, S., Diringer, M. N., Skolnick, B. E., & Steiner, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042991 · Cited by 1,167
Systematic overview of warfarin and its drug and food interactions
Holbrook, A. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1095 · Cited by 1,160
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hörtnagel, K., Pelz, H.-J., Lappegard, K., Seifried, E., Scharrer, I., Tuddenham, E. G. D., et al. (2004) · Nature · doi:10.1038/nature02214 · Cited by 1,134
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Self-citationCanadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Higashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Sconce, E. A., Khan, T. I., Wynne, H. A., Avery, P., Monkhouse, L., King, B. P., Wood, P., Kesteven, P., Daly, A. K., & Kamali, F. (2005) · Blood · doi:10.1182/blood-2005-03-1108 · Cited by 947
Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919
Self-citationRisk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Self-citationOptimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
Landefeld, C. S., & Beyth, R. J. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90285-w · Cited by 893
Roth, G. J., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108132 · Cited by 861
Warfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 812
Self-citationLong-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808 · cited 1×
“…approaches to establish the most appropriate range for different indications, as follows: (1) randomized trials in which patients are assigned to two different target ranges 142–145, 152, 153 ; (2 ) indirect Fixed minidose warfarin (1 mg daily) has been evaluated in a number of clinical settings.”
BackgroundHylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Self-citationBern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 788
Clinical Epidemiology - a basic science for clinical medicine
Hoffbrand, B. I. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.806.987-a · Cited by 783
Landefeld, C. S., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90564-0 · Cited by 778
Beyth, R. J., Quinn, L. M., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 773
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationDifferent Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Self-citationvan Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S., Petersen, P., Koudstaal, P. J., Chang, Y., & Hellemons, B. (2002) · JAMA · doi:10.1001/jama.288.19.2441 · Cited by 714
Identification of the gene for vitamin K epoxide reductase
Li, T., Chang, C.-Y., Jin, D.-Y., Lin, P.-J., Khvorova, A., & Stafford, D. W. (2004) · Nature · doi:10.1038/nature02254 · Cited by 707
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
D'Andrea, G., D'Ambrosio, R. L., Di Perna, P., Chetta, M., Santacroce, R., Brancaccio, V., Grandone, E., & Margaglione, M. (2005) · Blood · doi:10.1182/blood-2004-06-2111 · Cited by 699
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 671
Authors/Task Force Members, Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 644
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
Chiquette, E., Amato, M. G., & Bussey, H. I. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1641 · Cited by 596
FINAZZI, G., MARCHIOLI, R., BRANCACCIO, V., SCHINCO, P., WISLOFF, F., MUSIAL, J., BAUDO, F., BERRETTINI, M., Testa, S., D'ANGELO, A., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01340.x · Cited by 585
White, H. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.3.239 · Cited by 575
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Fihn, S. D., Callahan, C. M., Martin, D. C., McDonell, M. B., Henikoff, J. G., White, R. H., & National Consortium of Anticoagulation Clinics* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-11-199606010-00004 · Cited by 555
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Self-citationBleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
The Mode of Action of Vitamin K
Nelsestuen, G. L., Zytkovicz, T. H., & Howard, J. B. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42259-x · Cited by 528
Effect of Study Setting on Anticoagulation Control
van Walraven, C., Jennings, A., Oake, N., Fergusson, D., & Forster, A. J. (2006) · Chest · doi:10.1378/chest.129.5.1155 · Cited by 487
(1997) · Annals of Neurology · doi:10.1002/ana.410420606 · Cited by 480
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis
Heneghan, C., Alonso-Coello, P., Garcia-Alamino, J., Perera, R., Meats, E., & Glasziou, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68139-7 · Cited by 438
Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Dunn, A. S., & Turpie, A. G. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.901 · Cited by 434
Bleeding Complications in Oral Anticoagulant Therapy: An Analysis of Risk Factors
van der Meer, F. J. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130073007 · Cited by 433
(1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330102 · Cited by 425
van Es, R. F., Jonker, J. J., Verheugt, F. W., Deckers, J. W., & Grobbee, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09409-6 · Cited by 423
STAFFORD, D. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01419.x · Cited by 402
Makris, M., Greaves, M., Phillips, W. S., Kitchen, S., Rosendaal, F. R., & Preston, F. E. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655992 · Cited by 401
Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon
Haustein, K.-O. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996417 · Cited by 387
Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition
Whitlon, D. S., Sadowski, J. A., & Suttie, J. W. (1978) · Biochemistry · doi:10.1021/bi00601a003 · Cited by 384
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Hylek, E. M. (1998) · JAMA · doi:10.1001/jama.279.9.657 · Cited by 378
Self-citationAntithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
Salem, D. N., Stein, P. D., Al-Ahmad, A., Bussey, H. I., Horstkotte, D., Miller, N., & Pauker, S. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.457s · Cited by 374
Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
Saour, J. N., Sieck, J. O., Mamo, L. A. R., & Gallus, A. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220703 · Cited by 368
Beyth, R. J., Quinn, L., & Landefeld, C. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00010 · Cited by 360
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy
Harrison, L., Johnston, M., Massicotte, M. P., Crowther, M., Moffat, K., & Hirsh, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00006 · Cited by 359
Self-citation[Guidelines for the management of patients with atrial fibrillation. Executive summary].
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · PubMed · Cited by 356
Sawicki, P. T. (1999) · JAMA · doi:10.1001/jama.281.2.145 · Cited by 351
Witt, D. M., Sadler, M. A., Shanahan, R. L., Mazzoli, G., & Tillman, D. J. (2005) · Chest · doi:10.1378/chest.127.5.1515 · Cited by 348
Couban, S., Goodyear, M., Burnell, M., Dolan, S., Wasi, P., Barnes, D., MacLeod, D., Burton, E., Andreou, P., & Anderson, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.192 · Cited by 331
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
Eby, C., Milligan, P. E., Banet, G. A., Duncan, J., McLeod, H. L., & Gage, B. F. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-06-0379 · Cited by 322
Hemorrhagic Complications of Anticoagulant Therapy
Coon, W. W. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.133.3.386 · Cited by 316
Turpie, A. G. G., Hirsh, J., Gunstensen, J., Nelson, H., & Gent, M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92070-3 · Cited by 315
Self-citationPharmacogenetics of Warfarin Elimination and Its Clinical Implications
Takahashi, H., & Echizen, H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140080-00003 · Cited by 312
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
Aguilar, M. I., Hart, R. G., Kase, C. S., Freeman, W. D., Hoeben, B. J., García, R. C., Ansell, J. E., Mayer, S. A., Norrving, B., Rosand, J., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60970-1 · Cited by 306
Self-citationRandomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio
Kirkwood, T. B. L. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657371 · Cited by 300
Chesebro, J. H., Fuster, V., Elveback, L. R., McGoon, D. C., Pluth, J. R., Puga, F. J., Wallace, R. B., Danielson, G. K., Orszulak, T. A., Piehler, J. M., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90673-2 · Cited by 300
Fiessinger, J.-N., Huisman, M. V., Davidson, B. L., Bounameaux, H., Francis, C. W., Eriksson, H., Lundström, T., Berkowitz, S. D., Nyström, P., Thorsén, M., et al. (2005) · JAMA · doi:10.1001/jama.293.6.681 · Cited by 295
Samsa, G. P., Matchar, D. B., Goldstein, L. B., Bonito, A. J., Lux, L. J., Witter, D. M., & Bian, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.967 · Cited by 294
Cromheecke, M. E., Levi, M., Colly, L. P., de Mol, B. J., Prins, M. H., Hutten, B. A., Mak, R., Keyzers, K. C., & Büller, H. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02470-3 · Cited by 293
Andreotti, F., Testa, L., Biondi-Zoccai, G. G. L., & Crea, F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi485 · Cited by 289
Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
Pharmacogenomics: Challenges and Opportunities
Roden, D. M., Altman, R. B., Benowitz, N. L., Flockhart, D. A., Giacomini, K. M., Johnson, J. A., Krauss, R. M., McLeod, H. L., Ratain, M. J., Relling, M. V., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00007 · Cited by 282
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
Izzo, A. A., Di Carlo, G., Borrelli, F., & Ernst, E. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.06.039 · Cited by 278
Gitter, M. J., Jaeger, T. M., Petterson, T. M., Gersh, B. J., & Silverstein, M. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.725 · Cited by 276
Deveras, R. A. E., & Kessler, C. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00009 · Cited by 274
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man
Breckenridge, A., Orme, M., Wesseling, H., Lewis, R. J., & Gibbons, R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974154424 · Cited by 261
Interindividual variability in sensitivity to warfarin-Nature or nurture?
Loebstein, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117444 · Cited by 260
Geisen, C., Watzka, M., Sittinger, K., Steffens, M., Daugela, L., Seifried, E., Müller, C. R., Wienker, T. F., & Oldenburg, J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-04-0290 · Cited by 259
Risks of Oral Anticoagulant Therapy With Increasing Age
Torn, M., Bollen, W. L. E. M., van der Meer, F. J. M., van der Wall, E. E., & Rosendaal, F. R. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.13.1527 · Cited by 252
Fang, M. C., Go, A. S., Hylek, E. M., Chang, Y., Henault, L. E., Jensvold, N. G., & Singer, D. E. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00828.x · Cited by 249
Self-citationWarfarin Maintenance Dosing Patterns in Clinical Practice
Garcia, D., Regan, S., Crowther, M., Hughes, R. A., & Hylek, E. M. (2005) · Chest · doi:10.1378/chest.127.6.2049 · Cited by 241
Self-citationYuan, C.-S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M., & Moss, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00011 · Cited by 240
Aging and the Anticoagulant Response to Warfarin Therapy
Gurwitz, J. H., Avorn, J., Ross-Degnan, D., Choodnovskiy, I., & Ansell, J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-11-901 · Cited by 231
Self-citationHellemons, B. S. P., Langenberg, M., Lodder, J., Vermeer, F., Schouten, H. J. A., Lemmens, T., van Ree, J. W., & Knottnerus, J. A. (1999) · BMJ · doi:10.1136/bmj.319.7215.958 · Cited by 226
Fiore, L. D., Ezekowitz, M. D., Brophy, M. T., Lu, D., Sacco, J., & Peduzzi, P. (2002) · Circulation · doi:10.1161/hc0502.103329 · Cited by 224
Kovacs, M. J., Rodger, M., Anderson, D. R., Morrow, B., Kells, G., Kovacs, J., Boyle, E., & Wells, P. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00007 · Cited by 223
Multicentre randomised study of computerised anticoagulant dosage
Poller, L., Shiach, C., MacCallum, P., Johansen, A., Münster, A., Magalhäes, A., & Jespersen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04147-6 · Cited by 222
Schmitt, L., Speckman, J., & Ansell, J. (2003) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000011377.78585.63 · Cited by 221
Self-citationEHRLICH, H. J., HENZL, M. J., & GOMPERTS, E. D. (2002) · Haemophilia · doi:10.1046/j.1365-2516.2002.00532.x · Cited by 220
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Moll, S., & Ortel, T. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00001 · Cited by 214
Studies on the optical enantiomorphs of warfarin in man
Reilly, R. A. O. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974162348 · Cited by 213
Landefeld, C. S., Rosenblatt, M. W., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90565-2 · Cited by 211
Watson, H. G., Baglin, T., Laidlaw, S. L., Makris, M., & Preston, F. E. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03070.x · Cited by 211
The Stereoselective Interaction of Warfarin and Metronidazole in Man
O'Reilly, R. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950702 · Cited by 209
Comparing Self-Management of Oral Anticoagulant Therapy with Clinic Management: A Randomized Trial
Menéndez-Jándula, B., Souto, J. C., Oliver, A., Montserrat, I., Quintana, M., Gich, I., Bonfill, X., & Fontcuberta, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00006 · Cited by 208
Veeger, N. J. G. M., Piersma‐Wichers, M., Tijssen, J. G. P., Hillege, H. L., & van der Meer, J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05348.x · Cited by 207
Congenital malformations associated with the administration of oral anticoagulants during pregnancy
Lietman, P. S., Pettifor, J. M., & Benson, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80986-3 · Cited by 204
Interaction of Warfarin With Drugs, Natural Substances, and Foods
Greenblatt, D. J., & von Moltke, L. L. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004271404 · Cited by 199
A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses
Crowther, M. A., Ginsberg, J. B., Kearon, C., Harrison, L., Johnson, J., Massicotte, M. P., & Hirsh, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.46 · Cited by 199
Self-citationProtein C and the Development of Skin Necrosis During Anticoagulant Therapy
Broekmans, A. W., Bertina, R. M., Loeliger, E. A., Hofmann, V, & Klingemann, H.-G. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657378 · Cited by 199
Wilson, J.-A. S., Wells, P. S., Kovacs, M. J., Lewis, G. M., Martin, J. E., Burton, E., & Anderson, D. R. (2003) · Europe PMC (PubMed Central) · Cited by 197
Hillman, M. A., Wilke, R. A., Yale, S. H., Vidaillet, H. J., Caldwell, M. D., Glurich, I., Berg, R. L., Schmelzer, J., & Burmester, J. K. (2005) · Clinical Medicine & Research · doi:10.3121/cmr.3.3.137 · Cited by 196
Role of Vitamin-K-Dependent Proteins in Bone Metabolism
Price, P. A. (1988) · Annual Review of Nutrition · doi:10.1146/annurev.nu.08.070188.003025 · Cited by 196
Studies on Coumarin Anticoagulant Drugs: Initiation of Warfarin Therapy Without a Loading Dose
O'REILLY, R. A., & AGGELER, P. M. (1968) · Circulation · doi:10.1161/01.cir.38.1.169 · Cited by 192
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
Voora, D., Eby, C., Linder, M. W., Milligan, P. E., Bukaveckas, B. L., McLeod, H. L., Maloney, W., Clohisy, J., Burnett, S. R., Grosso, L., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0542 · Cited by 189
Boraks, P., Seale, J., Price, J., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00732.x · Cited by 189
Guidelines for prevention of thromboembolic events in valvular heart disease
Gohlke-Bärwolf, C., Acar, J., Oakley, C., Butchart, E., Burckhardt, D., Bodnar, E., Hall, R., Delahaye, J.-P., Horstkotte, D., Krémer, R., et al. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060739 · Cited by 186
Robert, A., & Chazouilleres, O. (1996) · Hepatology · doi:10.1002/hep.510240613 · Cited by 180
Sørensen, B., Johansen, P., Nielsen, G. L., Sørensen, J. C., & Ingerslev, J. (2003) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200307000-00007 · Cited by 178
Hylek, E. M., Regan, S., Go, A. S., Hughes, R. A., Singer, D. E., & Skates, S. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00008 · Cited by 178
Self-citationTreatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial
Crowther, M. A., Julian, J., McCarty, D., Douketis, J., Kovacs, M., Biagoni, L., Schnurr, T., McGinnis, J., Gent, M., Hirsh, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03125-1 · Cited by 177
Self-citationFactors affecting the maintenance dose of warfarin.
James, A. H., Britt, R. P., Raskino, C. L., & Thompson, S. G. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.8.704 · Cited by 176
Khan, T. I., Kamali, F., Kesteven, P., Avery, P., & Wynne, H. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05074.x · Cited by 176
Jiang, X., Williams, K. M., Liauw, W. S., Ammit, A. J., Roufogalis, B. D., Duke, C. C., Day, R. O., & McLachlan, A. J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02322.x · Cited by 172
Erhardtsen, E., Nony, P., Dechavanne, M., Ffrench, P., Boissel, J. P., & Hedner, U. (1998) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199811000-00003 · Cited by 171
LAUNBJERG, J., EGEBLAD, H., HEAF, J., NIELSEN, N. H., FUGLEHOLM, A. M., & LADEFOGED, K. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00358.x · Cited by 169
Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal
Odén, A., Fahlén, M., & Hart, R. G. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2004.11.025 · Cited by 163
Battistella, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.189 · Cited by 162
O'Donnell, M., Oczkowski, W., Fang, J., Kearon, C., Silva, J., Bradley, C., Guyatt, G., Gould, L., D'Uva, C., Kapral, M., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70536-1 · Cited by 161
Samsa, G. P., & Matchar, D. B. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018778914477 · Cited by 154
Petitti, D. B., Strom, B. L., & Melmon, K. L. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90260-3 · Cited by 154
Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement
Hering, D., Piper, C., Bergemann, R., Hillenbach, C., Dahm, M., Huth, C., & Horstkotte, D. (2005) · CHEST Journal · doi:10.1378/chest.127.1.53 · Cited by 153
Ansell, J., & Hughes, R. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90040-x · Cited by 151
Self-citationSchurgers, L. J., Shearer, M. J., Hamulyák, K., Stöcklin, E., & Vermeer, C. (2004) · Blood · doi:10.1182/blood-2004-04-1525 · Cited by 149
Vitamin K deficiency from dietary vitamin K restriction in humans
Suttie, J., Mummah-Schendel, L. L., Shah, D. V., Lyle, B., & Greger, J. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/47.3.475 · Cited by 144
The warfarin-sulfinpyrazone interaction: stereochemical considerations
Toon, S., Low, L. K., Gibaldi, M., Trager, W. F., O’Reilly, R. A., Motley, C. H., & Goulart, D. A. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.3 · Cited by 144
Matchar, D. B., Samsa, G. P., Cohen, S. J., Oddone, E. Z., & Jurgelski, A. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01131-2 · Cited by 141 · cited 1×
“The study by Matchar et al 287 also failed to show a significant improvement in TTR between the two models of care, although the AMS performed modestly better than UC.”
ResultEffect of 3.2%vs3.8% Sodium Citrate Concentration on Routine Coagulation Testing
Adcock, D. M., Kressin, D. C., & Marlar, R. A. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/107.1.105 · Cited by 141
Oral Anticoagulation Treatment in the Elderly
Palareti, G., Hirsh, J., Legnani, C., Manotti, C., D’Angelo, A., Pengo, V., Moia, M., Guazzaloca, G., Musolesi, S., & COCCHERI, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.470 · Cited by 140
Self-citationMaillard, C., Berruyer, M., Serre, C., DECHAVANNE, M., & Delmas, P. D. (1992) · Endocrinology · doi:10.1210/endo.130.3.1531628 · Cited by 139
Flier, J. S., Underhill, L. H., Wessler, S., & Gitel, S. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111007 · Cited by 138
Variation in Relative Risk of Venous Thromboembolism in Different Cancers
Thodiyil, P. A., & Kakkar, A. K. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613136 · Cited by 135
Ansell, J., Jacobson, A. K., Levy, J., Völler, H., & Hasenkam, J. M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.008 · Cited by 135
Self-citationMinidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis
Heaton, D. C., Han, D. Y., & Inder, A. (2002) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2002.d01-28.x · Cited by 133
The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins.
Malhotra, O. P., Nesheim, M. E., & Mann, K. G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89728-9 · Cited by 130
Raj, G., Kumar, R., & McKinney, W. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2721 · Cited by 127
Oral Anticoagulation and Hemorrhagic Complications in an Elderly Population With Atrial Fibrillation
Copland, M., Walker, I. D., & Tait, R. C. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.17.2125 · Cited by 125
Self management of oral anticoagulation: randomised trial
Fitzmaurice, D. A., Murray, E. T., McCahon, D., Holder, R. L., Raftery, J. P., Hussain, S., Sandhar, H., & Hobbs, R. F. (2005) · BMJ · doi:10.1136/bmj.38618.580903.ae · Cited by 125
Sconce, E. A., Khan, T. I., Mason, J. B., Noble, F., Wynne, H., & Kamali, F. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0773 · Cited by 124
Correction of Excessive Anticoagulation with Low-Dose Oral Vitamin K1
Weibert, R. T., Le, D. T., Kayser, S. R., & Rapaport, S. I. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00005 · Cited by 122
Harrington, D. J., Underwood, S., Morse, C., Shearer, M. J., Tuddenham, E. G. D., & Mumford, A. D. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0540 · Cited by 121
Segal, J. B., McNamara, R. L., Miller, M. R., Kim, N., Goodman, S. N., Powe, N. R., Robinson, K. A., & Bass, E. B. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.04329.x · Cited by 120
Effective Reversal of Warfarin-lnduced Excessive Anticoagulation with Low Dose Mtamin K1
Shetty, H. G. M., Backhouse, G., Bentley, D. P., & Routledge, P. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648371 · Cited by 120
Prospective comparative study of computer programs used for management of warfarin.
Poller, L., Wright, D., & Rowlands, M. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.4.299 · Cited by 118
Gadisseur, A., Breukink-Engbers, W. G. M., van der Meer, F. J. M., van den Besselaar, A. M. H. P., Sturk, A., & Rosendaal, F. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.21.2639 · Cited by 118
Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management
Ansell, J., Buttaro, M. L., Thomas, O. V., Knowlton, C. H., & Anticoagulation Guidelines Task Force (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100516 · Cited by 117
Self-citationPalareti, G., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., Devoto, G., Berrettini, M., Leali, N., et al. (1997) · PubMed · Cited by 115
Self-citationReduced Bone Density in Children on Long-Term Warfarin
Barnes, C. D., Newall, F. H., Ignjatović, V., Wong, P., Cameron, F. J., Jones, G., & Monagle, P. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000155943.07244.04 · Cited by 115
Gadisseur, A., Kaptein, A. A., Breukink-Engbers, W. G. M., et al. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00659.x · Cited by 111
Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans
O’Reilly, R. A., Trager, W. F., Rettie, A. E., & Goulart, D. A. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.149 · Cited by 108
O’Reilly, R. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020106 · Cited by 108
A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management
Cropp, J. S., & Bussey, H. I. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03782.x · Cited by 108
Effective reversal of warfarin-induced excessive anticoagulation with low dose vitamin K1.
Shetty, H. G. M., Backhouse, G., Bentley, D. P., et al. (1992) · PubMed · Cited by 106
Warfarin dosing and cytochrome P450 2C9 polymorphisms
Johnson, F. B., Longtine, J. A., Kucher, N., et al. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0083 · Cited by 105
Steffensen, F. H., Kristensen, K., Ejlersen, E., Dahlerup, J. F., & Sørensen, H. T. (1997) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1997.tb00023.x · Cited by 104
Manotti, C., Moia, M., Palareti, G., et al. (2001) · PubMed · Cited by 103
Self-citationhaplotype structure in European American warfarin patients and association with clinical outcomes
Veenstra, D., Blough, D. K., Higashi, M. K., Farin, F. M., Srinouanprachan, S., Rieder, M. J., & Rettie, A. E. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.019 · Cited by 102
Palareti, G., Legnani, C., Cosmi, B., Guazzaloca, G., Cini, M., & Mattarozzi, S. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01330.x · Cited by 100
Self-citationVisser, L. E., van Schaik, R. H., van Vliet, M., Trienekens, P. H., Smet, P. D., Vulto, A. G., Albert Hofman, D., van Duijn, C. M., & Stricker, B. H. C. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-12-0741 · Cited by 98
Oldenburg, J., Quenzel, E., Harbrecht, U., Fregin, A., Kreß, W., Müller, C. R., Hertfelder, H.-J., Schwaab, R., Brackmann, H., & Hanfland, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.2213036.x · Cited by 96
Soute, B. A. M., Vervoort, L., Claessens, J. G., & Thijssen, H. H. W. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0109 · Cited by 92
Accuracy of Laboratory and Portable Monitor International Normalized Ratio Determinations
Kaatz, S. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.17.1861 · Cited by 92
Palareti, G., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., Devoto, G., Berrettini, M., Leali, N., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1665430 · Cited by 88
Self-citationDouketis, J. D., Lane, A., Milne, J., & Ginsberg, J. S. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00098-x · Cited by 87
Jd, N., Winther, K., & Engelsen, J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613135 · Cited by 87
The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01118-9 · Cited by 83
Accuracy and Precision of a Portable Anticoagulation Monitor in a Clinical Setting
McCurdy, S. A. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.3.589 · Cited by 81
Reversal of excessive effect of regular anticoagulation
Pengo, V., Banzato, A., Garelli, E., Zasso, A., & Biasiolo, A. (1993) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199304050-00010 · Cited by 80
Willey, V. J., Bullano, M. F., Hauch, O., Reynolds, M. W., Wygant, G. D., Hoffman, L., Mayzell, G., & Spyropoulos, A. C. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90187-7 · Cited by 80
Resistance to Warfarin Due to Unrecognized Vitamin K Supplementation
O’Reilly, R. A., & Rytand, D. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030317 · Cited by 80
Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy
Regier, D. A. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051104 · Cited by 78
Dager, W. E., King, J. H., Regalia, R. C., Williamson, D., Gosselin, R. C., White, R. H. R., Tharratt, R. S., & Albertson, T. E. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1091 · Cited by 74
Fairweather, R. B., Ansell, J., van den Besselaar, A. M. H. P., Brandt, J. T., Bussey, H. I., Poller, L., Triplett, D. A., & White, R. H. R. (1998) · PubMed · Cited by 72
Self-citation
Cited by
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Antithrombotic Therapy for Venous Thromboembolic Disease
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., & Comerota, A. J. (2008) · Chest · doi:10.1378/chest.08-0658 · Cited by 1,996
Metadata
- Authors
- Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 133
- Issue
- 6
- Pages
- 160S-198S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2068476516
- Cited by
- 2,118
- References
- 256
- FWCI
- 145.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.